bioagelabs.comHealthcare / BioTech & PharmaFounded: 2015Funding to Date: $326.25MM
BioAge develops a pipeline of treatments to extend healthy lifespan by targeting the molecular causes of aging by using its discovery platform, which combines quantitative analysis of proprietary longitudinal human samples with detailed health records tracking individuals over the lifespan, to map out the key molecular pathways that impact healthy human aging.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
02/13/2024 | Series D-1 | $24.39MM | $xx.xx | $440.23MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
11,887,535
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
02/13/2024 | Series D | $170MM | $xx.xx | $440.23MM | Sofinnova Investments, Longitude Capital, RA Capital, Cormorant Asset Management, RTW Investments, SV Health Investors, OrbiMed Advisors, Sands Capital, Pivotal bioVenture Partners, Osage University Partners, Lilly Ventures, Amgen Ventures, Andreessen Horowitz | |
Price per Share
$xx.xx
Shares Outstanding
49,713,403
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Sofinnova Investments, Longitude Capital, RA Capital, Cormorant Asset Management, RTW Investments, SV Health Investors, OrbiMed Advisors, Sands Capital, Pivotal bioVenture Partners, Osage University Partners, Lilly Ventures, Amgen Ventures, Andreessen Horowitz
|
||||||
12/03/2020 | Series C | $95MM | $xx.xx | $270.18MM | Andreessen Horowitz, Elad Gil, Kaiser Foundation Hospitals, AARP Foundation, Phi-X Capital, Caffeinated Capital, Redpoint Ventures, PEAR Ventures, AME Cloud Ventures, Felicis Ventures | |
Price per Share
$xx.xx
Shares Outstanding
16,076,886
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Andreessen Horowitz, Elad Gil, Kaiser Foundation Hospitals, AARP Foundation, Phi-X Capital, Caffeinated Capital, Redpoint Ventures, PEAR Ventures, AME Cloud Ventures, Felicis Ventures
|
||||||
01/24/2019 | Series B | $22.93MM | $xx.xx | $86.05MM | Felicis Ventures, Andreessen Horowitz, Caffeinated Capital, PEAR Ventures, AME Cloud Ventures, Khosla Ventures, Redpoint Ventures | |
Price per Share
$xx.xx
Shares Outstanding
7,455,241
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Felicis Ventures, Andreessen Horowitz, Caffeinated Capital, PEAR Ventures, AME Cloud Ventures, Khosla Ventures, Redpoint Ventures
|
||||||
07/28/2017 | Series A-4 | $54,998 | $xx.xx | $43.84MM | Andreessen Horowitz, Felicis Ventures, AME Cloud Ventures, PEAR Ventures, Caffeinated Capital, Elad Gil | |
Price per Share
$xx.xx
Shares Outstanding
27,643
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Andreessen Horowitz, Felicis Ventures, AME Cloud Ventures, PEAR Ventures, Caffeinated Capital, Elad Gil
|
||||||
07/28/2017 | Series A-3 | $250,006 | $xx.xx | $43.84MM | Andreessen Horowitz, Felicis Ventures, AME Cloud Ventures, PEAR Ventures, Caffeinated Capital, Elad Gil | |
Price per Share
$xx.xx
Shares Outstanding
203,821
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Andreessen Horowitz, Felicis Ventures, AME Cloud Ventures, PEAR Ventures, Caffeinated Capital, Elad Gil
|
||||||
07/28/2017 | Series A-2 | $1.81MM | $xx.xx | $43.84MM | Andreessen Horowitz, Felicis Ventures, AME Cloud Ventures, PEAR Ventures, Caffeinated Capital, Elad Gil | |
Price per Share
$xx.xx
Shares Outstanding
2,948,071
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Andreessen Horowitz, Felicis Ventures, AME Cloud Ventures, PEAR Ventures, Caffeinated Capital, Elad Gil
|
||||||
07/28/2017 | Series A-1 | $11.82MM | $xx.xx | $43.84MM | Andreessen Horowitz, Felicis Ventures, AME Cloud Ventures, PEAR Ventures, Caffeinated Capital, Elad Gil | |
Price per Share
$xx.xx
Shares Outstanding
4,753,466
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Andreessen Horowitz, Felicis Ventures, AME Cloud Ventures, PEAR Ventures, Caffeinated Capital, Elad Gil
|